In the past several years, the importance of microRNA (miRNA) in cancer cells has been
recognized. Proper control of miRNA expression is essential for maintaining a steady state of …

Breast cancer patients often develop metastatic disease years after resection of the primary
tumor. The patients are asymptomatic because the disseminated cells appear to become …

The existence of circulating microRNAs (miRNAs) in the blood of cancer patients has raised
the possibility that miRNAs may serve as a novel diagnostic marker. However, the secretory …

Extracellular vesicles (EVs), such as exosomes and microvesicles, are released by different
cell types and participate in physiological and pathophysiological processes. EVs mediate …

Cancer cells secrete small membranous extracellular vesicles (EVs) into their microenvironment
and circulation. Although their potential as cancer biomarkers has been promising, the …

Since comprehensive analysis of the mammalian genome revealed that the majority of
genomic products are transcribed in long non‐coding RNA (lnc RNA ), increasing attention has …

Drug resistance represents one of the greatest challenges in cancer treatment. Cancer stem
cells (CSCs), a subset of cells within the tumor with the potential for self-renewal, …

Despite the therapeutic potential of nucleic acid drugs, their clinical application has been
limited in part by a lack of appropriate delivery systems. Exosomes or microvesicles are small …

The effects of autonomic innervation of tumors on tumor growth remain unclear. Here we
developed a series of genetic techniques to manipulate autonomic innervation in a tumor- and …

Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of
origin and change the functions and phenotypes of other cells. These features indicate …